CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Pharmaceutical Advisory Committee Formulary Working Group for Health Technology Assessments

The Pharmaceutical Advisory Committee Formulary Working Group for Health Technology Assessments (FWG-HTA) includes representatives from the federal, provincial, and territorial health ministries, and related health organizations. The FWG-HTA provides advice on CADTH optimal use projects. Working group members also facilitate effective jurisdictional sharing of optimal use information.

Chair
British Columbia Clifford Lo
Members
Alberta Sandra Rees
Non-Insured Health Benefits Karen Fortin
Manitoba Amy Yu
New Brunswick Tina LeClerc
Newfoundland and Labrador Colleen Ryan
Nova Scotia Nicole Cluett
Ontario Christine Seager
Prince Edward Island Marsha Cusack
Yukon Territory Yi Fang Zhang
Correctional Service Canada Alka Bhalla
Canadian Armed Forces Michelle Sullivan
Veterans Affairs Canada Anne Bastarache
Pan-Canadian Pharmaceutical Alliance Sang Mi Lee
Observers
Health Canada Barry Jones
PMPRB Dianne Breau
Canadian Institute for Health Information Cathy MacMillan
INESSS Marie Hotte
Canadian Blood Services Sylvain Grenier